logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10350207 B1

PDFFull Text
Date of Patent:
Jul. 16, 2019

Filed:

Jun. 06, 2016

Pac-1 combination therapy

Applicant:

The Board of Trustees of the University of Illinois, Urbana, IL (US);

Inventors:

Paul J. Hergenrother, Champaign, IL (US);

Jessie Peh, Champaign, IL (US);

Assignee:

The Board of Trustees of the University of Illinois, Urbana, IL (US);

Attorneys:

Haukaas Fortius PLLC

Michael H. Haukaas

Primary Examiner:

Craig D Ricci

Assistant Examiner:

Janet L Coppins

Int. Cl.
CPC ...
A61K 31/506 (2006.01); A61K 31/495 (2006.01); A61K 45/06 (2006.01); A61K 31/4184 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61P 35/02 (2006.01); A61K 31/519 (2006.01); A61K 9/00 (2006.01); A61K 9/12 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01);
U.S. Cl.
CPC ...
A61K 31/506 (2013.01); A61K 9/0019 (2013.01); A61K 9/12 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 9/4866 (2013.01); A61K 31/4184 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/495 (2013.01); A61K 31/519 (2013.01); A61K 45/06 (2013.01); A61P 35/02 (2018.01); A61K 2300/00 (2013.01);
Abstract

The invention provides compositions and methods for the induction of cancer cell death. The compositions and methods of using them include use of compositions in therapy for the treatment of cancer and for the selective induction of apoptosis in cancer cells. The drug combinations described herein can be synergistic and can have lower neurotoxicity effects than the same amounts of other compounds and combinations of compounds, and can be effective when a particular cancer has become resistant to previously administered therapies.

Find Patent Forward Citations

Hergenrother, Paul. (2019). Pac-1 combination therapy (U.S. Patent No. 10350207). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10350207

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…